Form 4 for ASTH Astrana Health, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001250853-22-000120 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-09 | 2022-12-07 | ASTH | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp | 10% | M - OptEx | $10.49 | +107.6K | 10.25M | +1% | +$1.13M |
| DM | 2022-12-09 | 2022-12-07 | ASTH | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp | 10% | M - OptEx | — | -107.6K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-07 | M | A | 52,262 | $11.00 | 10,299,259 | D | — | — | (F1) These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person. |
| 2 | Common | Common Stock | 2022-12-07 | M | A | 55,337 | $10.00 | 10,246,997 | D | — | — | (F1) These shares are owned directly by the Reporting Person, and indirectly by Kenneth Sim, Thomas Lam, and Albert Young, each of whom is a director, officer and shareholder of the Reporting Person. |
| 3 | Derivative | Warrants to purchase Common Stock | 2022-12-07 | M | D | 55,337.13 | — | 0 | D | $10.00 · 2017-12-08 to 2022-12-08 | 55,337.13 Common Stock | (F2) On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share. |
| 4 | Derivative | Warrants to purchase Common Stock | 2022-12-07 | M | D | 52,262.84 | — | 0 | D | $11.00 · 2017-12-08 to 2022-12-08 | 52,262.84 Common Stock | (F2) On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into certain securities of the Issuer and other consideration, including (i) a warrant to purchase 55,337.13 shares of common stock of the Issuer at an exercise price of $10.00 per share and (ii) a warrant to purchase 52,262.84 shares of common stock of the Issuer at an exercise price of $11.00 per share. |